Pre-eclampsia and increased cardiovascular risk

British Medical Journal

Volumn 335, Issue 7627, 2007, Pages 945-946

  Magee, L A ^a   Von Dadelszen, P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EDITORIAL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MATERNAL HYPERTENSION; METABOLIC SYNDROME X; PRACTICE GUIDELINE; PREECLAMPSIA; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PRENATAL CARE; RISK FACTORS;

EID: 36348989565     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39337.427500.80     Document Type: Editorial

References (13)

1. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004;109:672-93.
2. Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007;176:S1-44.
3. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-8.
4. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005;366:1797-803.
5. Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007 doi: 10.1136/bmj.39335.385301.BE.
6. Magnussen EB, Vatten LJ, Nilsen TIL, Salvesen KÅ, Smith GD, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 2007 doi: 10.1136/bmj.39366.416817.BE.
7. Forest JC, Girouard J, Masse J, Moutquin JM, Kharfi A, Ness RB, et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005;105:1373-80.
8. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;325:157-60.
9. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
10. Broedl UC, Geiss HC, Parhofer KG. Comparison of current guidelines for primary prevention of coronary heart disease: risk assessment and lipid-lowering therapy. J Gen Intern Med 2003;18:190-5.
11. Campbell NR, Khan NA, Grover SA. Barriers and remaining questions on assessment of absolute cardiovascular risk as a starting point for interventions to reduce cardiovascular risk. J Hypertens 2006;24:1683-5.
12. King AC, Castro C, Wilcox S, Eyler AA, Sallis JF, Brownson RC. Personal and environmental factors associated with physical inactivity among different racial-ethnic groups of US middle-aged and older-aged women. Health Psychol 2000;19:354-64.
13. Chen J, Millar WJ. Starting and sustaining physical activity. Health Rep 2001;12:33-43.